跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 147 条关于
“mTORC2”
全部
147
临床试验
112
药物
17
机构
0
资讯
18
去年
Dual mTORC1/2 Inhibitor BI 860585 Shows Promise in Phase I Breast Cancer Trial
10个月前
Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy
9个月前
Aeovian Pharmaceuticals Secures $55 Million Series B to Advance First-in-Class mTORC1 Inhibitor for Rare Epilepsy
10个月前
Galmed Reports Promising Triple-Drug Combination for Gastrointestinal Cancers
去年
CRISPR Screen Identifies GATOR1 Complex as Key Suppressor of MYC-Driven Lymphomas with Therapeutic Implications
去年
Gut Metabolite Imidazole Propionate Identified as Novel Atherosclerosis Driver and Therapeutic Target
去年
Galmed's Aramchol Shows Promising Results in Enhancing Regorafenib's Efficacy Against GI Cancers
11个月前
Faeth Therapeutics Raises $25M to Advance PIKTOR Therapy After 80% Response Rate in Endometrial Cancer
10个月前
ESMO 2025 Highlights Transformative Advances in Cancer Treatment: ADCs Move to Earlier Disease Settings While AI Integration Accelerates
上个月
KAIST Researchers Uncover Molecular Switch Linking Amino Acid Sensing to mTORC1 Activation, Opening New Avenues for Cancer Therapy
第 1 页,共 2 页
上一页
下一页